US Oncology - Texas Oncology - Tyler

Tyler, Texas 75702

We've found

3 trials

at this facility

A Phase 1b/2 Study of Alvocidib Plus Decitabine in Patients With MDS

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Tyler, TX

First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Tyler, TX

Phase I, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Tyler, TX

Use our guide to learn which trials are right for you!